Molecular PET imaging of HSV1-tk reporter gene expression using [18F]FEAU

Nature Protocols

Volumn 2, Issue 2, 2007, Pages 416-423

  Soghomonyan, Suren ^a   Hajitou, Amin ^a   Rangel, Roberto ^a   Trepel, Martin ^b   Pasqualini, Renata ^a   Arap, Wadih ^a   Gelovani, Juri G ^a   Alauddin, Mian M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 ETHYL 2' FLUOROURACIL ARABINOSIDE F 18; FLUORODEOXYGLUCOSE F 18; GANCICLOVIR; RADIOISOTOPE; THYMIDINE KINASE; UNCLASSIFIED DRUG; 2' FLUORO 5 ETHYLARABINOSYLURACIL; 2'-FLUORO-5-ETHYLARABINOSYLURACIL; DRUG DERIVATIVE; FLUORINE; URACIL ARABINOSIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS 1; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMAGE ANALYSIS; ISOTOPE LABELING; MAMMAL CELL; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN HYDROLYSIS; PROTEIN PURIFICATION; REPORTER GENE; TRANSGENE; TUMOR CELL LINE; TUMOR XENOGRAFT; ANIMAL; CHEMICAL STRUCTURE; GENE EXPRESSION PROFILING; GENE TARGETING; GENE VECTOR; GENETICS; HUMAN; METABOLISM; METHODOLOGY;

ANIMALIA; HUMAN HERPESVIRUS 1; MAMMALIA;

ANIMALS; ARABINOFURANOSYLURACIL; CELL LINE, TUMOR; FLUORINE RADIOISOTOPES; GENE EXPRESSION PROFILING; GENE TARGETING; GENES, REPORTER; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MOLECULAR STRUCTURE; POSITRON-EMISSION TOMOGRAPHY; THYMIDINE KINASE; TRANSGENES;

EID: 34347263787     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2007.49     Document Type: Article

References (36)

1. Tjuvajev, J.G. et al. Imaging the expression of transfected genes in vivo. Cancer Res. 55, 6126-6132 (1995).
2. Tjuvajev, J.G. et al. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy. Cancer Res. 56, 4087-4095 (1996).
3. Tjuvajev, J.G. et al. Imaging herpes virus thymidine kinase gene transfer and expression by positron emission tomography. Cancer Res. 58, 4333-4341 (1998).
4. Tjuvajev, J.G. et al. Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression. J. Nucl. Med. 43, 1072-1083 (2002).
5. 18F]FHPG): A potential imaging agent of viral infection and gene therapy using PET. Nucl. Med. Biol. 23, 787-792 (1996).
6. 18F]FHBG): A new potential imaging agent for viral infection and gene therapy using PET. Nucl. Med. Biol. 25, 175-180 (1998).
7. 18F]-FHPG) in vitro and in vivo as a probe for PET imaging of gene incorporation and expression in tumors. Nucl. Med. Biol. 26, 371-376 (1999).
8. Alauddin, M.M., Shahinian, A., Gordon, E.M., Bading, J.R. & Conti, P.S. Pre-clinical evaluation of the penciclovir analog 9-(4-[18F]-fluoro-3-hydroxymethylbutyl)guanine for in vivo measurement of suicide gene expression with PET. J. Nucl. Med. 42, 1682-1690 (2001).
9. Jacobs, A. et al. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type-1 mutant vectors in vivo. Cancer Res. 61, 2983-2995 (2001).
10. Haberkorn, U. et al. Monitoring gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: Uptake of specific substrates. J. Nucl. Med. 38, 287-294 (1997).
11. Tjuvajev, J.G. et al. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo. Cancer Res. 59, 5186-5193 (1999).
12. Haberkorn, U. et al. Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase. Nucl. Med. Biol. 25, 367-373 (1998).
13. Gambhir, S.S. et al. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc. Natl. Acad. Sci. USA 96, 2333-2338 (1999).
14. Yu, Y. et al. Quantification of gene expression by imaging reporter gene expression in living animals. Nat. Med. 6, 933-937 (2000).
15. Tjuvajev, J.G. et al. A general approach to the non-invasive imaging of transgenes using cis-linked herpes virus thymidine kinase. Neoplasia 1, 315-320 (1999).
16. 18F]-Fluoropenciclovir: An improved reporter probe for imaging HSV-tk reporter gene expression in vivo using PET. J. Nucl. Med. 42, 96-105 (2001).
17. 18F]-FMAU . J. Labelled Compd. Radiopharm. 45, 583-590 (2002).
18. Alauddin, M.M., Shahinian, A., Gordon, E.M. & Conti, P.S. Evaluation of 2′-deoxy-2′-fluoro-5-methyl-1-β-d- arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivo. Mol. Imaging 1, 74-81 (2002).
19. 18F]fluoro-5-methyl-1-β-d-arabinofuranosyluracil and its 5-substituted nucleosides. J. Labelled Compd. Radiopharm. 4, 285-289 (2003).
20. 18F]-fluoro-5- fluoro-1-beta-d-arabinofuranosyluracil as a potential PET imaging agent for gene expression. J. Nucl. Med. 45, 2063-2069 (2004).
21. 18F]FCAU), and their biological evaluation as markers for gene expression. Nucl. Med. Biol. 31, 399-405 (2004).
22. 18F]-FEAU) as markers for suicide gene expression. Eur. J. Nucl. Med. Mol. Imaging (Jan 6 2007, E. Pub).
23. Alauddin, M.M., Shahinian, A. & Conti, P.S. Evaluation of 2′-deoxy-2′-fluoro-5- substituted-1-beta-d-arabinofuranosyluracils as markers for suicide gene expression in breast cancer cells. J. Nucl. Med. 46, 35 (2005).
24. 18F-FEAU as a radiotracer for herpes simplex virus thymidine kinase gene expression: in vitro comparison with other PET tracers. Nucl. Med. Commun. 27, 25-30 (2006).
25. 3H]PCV for monitoring reporter gene expression with wild type and mutant herpes simplex virus type 1 thymidine kinase in cell culture. Mol. Imaging Biol. 7, 296-303 (2005).
26. Tseng, J.C. et al. Tumor specific in vivo transfection with HSV-1 thymidine kinase gene using a Sindbis viral vector as a basis for prodrug ganciclovir activation and PET. J. Nucl. Med. 47, 1136-1143 (2006).
27. Hajitou, A., Pasqualini, R. & Arap, W. Vascular targeting: Recent advances and therapeutic perspectives. Trends Cardiovasc. Med. 16, 80-88 (2006).
28. Hajitou, A. et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 125, 385-398 (2006).
29. Ivanenkov, V.V., Felici, F. & Menon, A.G. Targeted delivery of multivalent phage display vectors into mammalian cells. Biochim. Biophys. Acta 1448, 463-472 (1999).
30. Larocca, D. et al. Gene transfer to mammalian cells using genetically targeted filamentous bacteriophage. FASEB J. 13, 727-734 (1999).
31. Poul, M.A. & Marks, J.D. Targeted gene delivery tomammalian cells by filamentous bacteriophage. J. Mol. Biol. 288, 203-211 (1999).
32. Sergeeva, A., Kolonin, M.G., Molldrem, J.J., Pasqualini, R. & Arap, W. Display technologies: Application for the discovery of drug and gene delivery agents. Adv. Drug Deliv. Rev. 58, 1622-1654 (2006).
33. Hajitou, A. et al. Design and construction of targeted AAVP for mammalian cell transduction. Nat. Protoc. DOI: 10.1038/ nprot.2007.51.
34. 18F]-fluoro-arabinonucleosides. J. Fluorine Chem. 106 87-91 (2000).
35. Tann, C.H., Brodfuehrer, P.R., Brundidge, S.P., Sapino, C. Jr & Howell, H.G. Fluorocarbohydrtaes in synthesis. An efficient synthesis of 1-(2-deoxy-2-fluoro-β- d-arabimofuranosyluracil)-5-iodouracil (β-FIAU) and 1-(2-deoxy-2-fluoro-β-d-arabimofuranosyl) thymine (β-FMAU). J. Org. Chem. 50, 3644-3647 (1985).
36. Watanabe, K.A. et al. Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-β-d-arabionofuranosyl)uracils. J. Med. Chem. 27, 91-94 (1984).